NCT01214577View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, 0.015%, in Patients With Photo-damaged Skin

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Photo-damage
Interventions
DRUG

PEP005 (ingenol mebutate) Gel

0.015%

Trial Locations (2)

4102

Specialist Connect, Woolloongabba

4217

The Skin Centre, Benowa

Sponsors

Lead Sponsor

Peplin
All Listed Sponsors
lead

Peplin

INDUSTRY

NCT01214577 - Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, 0.015%, in Patients With Photo-damaged Skin | Biotech Hunter | Biotech Hunter